Docs Who Lift GLP-1 meds and macular degeneration
18 snips
Jun 23, 2025 Join Dr. Brueger, an ophthalmologist and retina specialist, as he dives into age-related macular degeneration (AMD) and its potential links to GLP-1 medications. Discover the types and causes of AMD, including key risk factors like genetics and lifestyle. The fascinating conversation also explores how diabetes and its treatments relate to eye health. Dr. Brueger clarifies misconceptions about vision loss from macular degeneration, making it both informative and engaging.
AI Snips
Chapters
Transcript
Episode notes
AMD Prevalence Increases With Age
- Macular degeneration prevalence increases with age, affecting about 10% of people over 50.
- Risk grows from 0.2-2% in ages 50-59 to 15-30% in people over 80, showing its strong age correlation.
Wet AMD Causes Rapid Vision Loss
- Wet (neovascular) AMD involves blood vessel growth and leakage, leading to rapid vision loss.
- It is a progression from dry AMD and requires early treatment with injections to shrink vessels and prevent damage.
Retrospective Studies Have Limits
- Retrospective studies on GLP-1 receptor agonists and AMD risk have limitations due to misclassification and diagnosis challenges.
- Many patients labeled with AMD may have other eye conditions, making data interpretation tricky and less alarming than headlines suggest.